Loading…
Reported covered position: Office of Senator Thad Cochran
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Consolidated Appropriations Act, 2017
Client: BAVARIAN NORDIC WASHINGTON, DC, INC. · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Authorization and appropriations for medical countermeasures development and procurement, including HR 244, Consolidated Appropriations Act 2017, Division H - Labor, HHS and Education, and FY 2018 Labor-HHS Appropriations bill.
Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BAVARIAN NORDIC WASHINGTON, DC, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2017 · second_quarter · Q2
Authorization and appropriations for medical countermeasures development and procurement, including HR 244, Consolidated Appropriations Act 2017, Division H - Labor, HHS and Education, and FY 2018 Labor-HHS Appropriations bill.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
SEQIRUS, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2017 · second_quarter · 2T
Source: Senate LDA
| GENERIC PHARMACEUTICAL ASSOCIATION |
| 11 |
| 2013–2015 |
| CARECORE NATIONAL | 10 | 2014–2016 |
| ARTHROSCOPY ASSOCIATION OF NORTH AMERICA | 9 | 2015–2017 |
| HELEN KELLER NATIONAL CENTER | 9 | 2015–2017 |
| ALL AMERICAN MEDICAL SUPPLIES | 7 | 2013–2014 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 7 | 2016–2017 |
| FRIENDS OF THE GLOBAL FIGHT | 6 | 2014–2015 |
| MEMORIAL HOSPITAL AT GULFPORT | 6 | 2013–2014 |
| SINGING RIVER HOSPITAL SYSTEM | 6 | 2013–2014 |
| ADVANCED DIABETES SUPPLY | 5 | 2013 |
| HARTFORD HEALTHCARE | 5 | 2013–2014 |
| MEDENVIOS HEALTHCARE | 5 | 2013–2014 |
| HATTIESBURG CLINIC | 4 | 2014 |
| NATIONAL GROUND WATER ASSOCIATION | 4 | 2014 |
| OCHSNER HOSPITAL SYSTEM | 4 | 2014 |
| PATHGROUP, INC. | 4 | 2014 |
| DIABETES SPECIALTY CENTER LLC | 3 | 2013 |
| NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS | 3 | 2015 |
| PLASMA PROTEIN THERAPEUTICS ASSOCIATION | 3 | 2015–2016 |
| SEQIRUS, INC. | 3 | 2017 |
| DOCTOR DIABETIC SUPPLY, INC. | 2 | 2013 |
| AMERISOURCEBERGEN | 1 | 2013 |
| DEAN'S NURSING POLICY COALITION (INFORMAL COALITION) | 1 | 2014 |
| GLOBAL MEDICAL DIRECT | 1 | 2013 |
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
Preservation of Access for Seniors in Medicare Advantage Act of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
Preservation of Access for Seniors in Medicare Advantage Act of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
Strengthening Public Health Emergency Response Act of 2016
Client: BAVARIAN NORDIC WASHINGTON, DC, INC. · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Legislative & regulatory issues related to biodefense countermeasure development, including the FY17 Labor HHS Appropriations Bill. H.R. 3299, Strengthening Public Health Emergency Response Act of 2016 S. 2055, Medical Countermeasure Innovation Act of 2016; H.R. 6, 21st Century Cures Act, provisions related to medical countermeasures.
21st Century Cures Act
Client: BAVARIAN NORDIC WASHINGTON, DC, INC. · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Legislative & regulatory issues related to biodefense countermeasure development, including the FY17 Labor HHS Appropriations Bill. H.R. 3299, Strengthening Public Health Emergency Response Act of 2016 S. 2055, Medical Countermeasure Innovation Act of 2016; H.R. 6, 21st Century Cures Act, provisions related to medical countermeasures.
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
Medical Countermeasure Innovation Act of 2016
Client: BAVARIAN NORDIC WASHINGTON, DC, INC. · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Legislative & regulatory issues related to biodefense countermeasure development, including the FY17 Labor HHS Appropriations Bill. H.R. 3299, Strengthening Public Health Emergency Response Act of 2016 S. 2055, Medical Countermeasure Innovation Act of 2016; H.R. 6, 21st Century Cures Act, provisions related to medical countermeasures.
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Implementation of Public Law No. 111-148, provisions affecting community health centers; H.R. 2, Medicare Access & CHIP Reauthorization Act of 2015, provisions affecting community health centers; funding for community health centers, generally.
Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
Preservation of Access for Seniors in Medicare Advantage Act of 2015
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
21st Century Cures Act
Client: PLASMA PROTEIN THERAPEUTICS ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
Safeguarding America's Pharmaceuticals Act of 2013
Client: AMERISOURCEBERGEN · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 1919/S. 957, Drug Supply Chain Security Act
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues
Drug Quality and Security Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues
Drug Quality and Security Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues
Drug Quality and Security Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues
To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
Client: AMERISOURCEBERGEN · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 800/S. 806 - A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
FDA User Fee Protection Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues
FDA User Fee Protection Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues
FDA User Fee Protection Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 3204, Drug Quality and Security Act H.R. 2725, S. 1413, FDA User fee sequestration issues
Preserve Access to Affordable Generics Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Issues relating to patent settlements including S. 214, Preserve Access to Generics Act
Preserve Access to Affordable Generics Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Issues relating to patent settlements including S. 214, Preserve Access to Generics Act
Preserve Access to Affordable Generics Act
Client: GENERIC PHARMACEUTICAL ASSOCIATION · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
Issues relating to patent settlements including S. 214, Preserve Access to Generics Act
A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
Client: AMERISOURCEBERGEN · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 800/S. 806 - A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.
Drug Supply Chain Security Act
Client: AMERISOURCEBERGEN · Firm: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
H.R. 1919/S. 957, Drug Supply Chain Security Act
Labor, Health and Human Services and Education Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEQIRUS, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2017 · first_quarter · Q1
Labor, Health and Human Services and Education Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2017 · second_quarter · 2T
Lobby on appropriations legislation to create training program for advance arthroscopic surgical techniques within the DOD.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
HELEN KELLER NATIONAL CENTER via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2017 · second_quarter · 2T
FY17 Labor-HHS-Education Appropriations Legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2017 · second_quarter · 2T
FY17 Appropriations Bills
FY17 Appropriations Bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEQIRUS, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2017 · first_quarter · RR
FY17 & FY18 Labor, Health and Human Services and Education Appropriations Bills
FY17 & FY18 Labor, Health and Human Services and Education Appropriations Bills
BAVARIAN NORDIC WASHINGTON, DC, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2017 · first_quarter · Q1
Legislative & regulatory issues related to biodefense countermeasure development, including the FY17 Labor HHS Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2017 · first_quarter · Q1
Lobby on appropriations legislation to create training program for advance arthroscopic surgical techniques within the DOD.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
HELEN KELLER NATIONAL CENTER via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2017 · first_quarter · Q1
FY17 Labor-HHS-Education Appropriations Legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2017 · first_quarter · Q1
FY17 Appropriations Bills
FY17 Appropriations Bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC WASHINGTON, DC, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · fourth_quarter · 4A
Legislative & regulatory issues related to biodefense countermeasure development, including the FY17 Labor HHS Appropriations Bill. H.R. 3299, Strengthening Public Health Emergency Response Act of 2016 S. 2055, Medical Countermeasure Innovation Act of 2016; H.R. 6, 21st Century Cures Act, provisions related to medical countermeasures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · first_quarter · 1T
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · fourth_quarter · Q4
FY17 Appropriations Bills
FY17 Appropriations Bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELEN KELLER NATIONAL CENTER via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · fourth_quarter · Q4
FY17 Labor-HHS-Education Appropriations Legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC WASHINGTON, DC, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · fourth_quarter · Q4
Legislative & regulatory issues related to biodefense countermeasure development, including the FY17 Labor HHS Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · third_quarter · Q3
Create a training program within VA for advanced arthroscopic surgical techniques.
Lobby on appropriations legislation to create training program for advance arthroscopic surgical techniques within the DOD.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · second_quarter · Q2
Lobby on appropriations legislation to create training program for advance arthroscopic surgical techniques within the DOD.
Create a training program within VA for advanced arthroscopic surgical techniques.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · first_quarter · Q1
Heath care issues related to training military orthopedic surgeons on arthroscopic techniques to repair injuries on large joints on military service members.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
FORREST GENERAL HOSPITAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · third_quarter · Q3
Health Care Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORREST GENERAL HOSPITAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · second_quarter · Q2
Health Care Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC WASHINGTON, DC, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · third_quarter · Q3
Legislative & regulatory issues related to biodefense countermeasure development, including the FY17 Labor HHS Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELEN KELLER NATIONAL CENTER via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · third_quarter · Q3
FY17 Labor-HHS-Education Appropriations Legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · third_quarter · Q3
FY17 Appropriations Bills
FY17 Appropriations Bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES MEDICAL SUPPLY via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · second_quarter · Q2
Medicare DME reimbursement, Audit issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · second_quarter · Q2
FY17 Appropriations Bills
FY17 Appropriations Bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELEN KELLER NATIONAL CENTER via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · second_quarter · Q2
FY17 Labor-HHS-Education Appropriations Legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC WASHINGTON, DC, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · second_quarter · Q2
Legislative & regulatory issues related to biodefense countermeasure development, including the FY17 Labor HHS Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED INFUSION SERVICES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · first_quarter · Q1
Medicare Billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES MEDICAL SUPPLY via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · first_quarter · Q1
Medicare DME reimbursement, Audit issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FORREST GENERAL HOSPITAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · first_quarter · Q1
Health Care Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · first_quarter · Q1
FY17 Appropriations Bills
FY17 Appropriations Bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · first_quarter · Q1
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · first_quarter · RA
The Fiscal Year 2017 Appropriations bills and their accompanying reports.
The Fiscal Year 2017 Appropriations bills and their accompanying reports.
CARECORE NATIONAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · first_quarter · 1T
Health care financing; implementation of "Protecting Access to Medicare Act of 2014".
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELEN KELLER NATIONAL CENTER via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · first_quarter · Q1
FY17 Labor-HHS-Education Appropriations Legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC WASHINGTON, DC, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2016 · first_quarter · Q1
Legislative & regulatory issues related to biodefense countermeasure development, including the FY17 Labor HHS Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · fourth_quarter · Q4
Heath care issues related to training military orthopedic surgeons on arthroscopic techniques to repair injuries on large joints on military service members.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · third_quarter · Q3
Heath care issues related to training military orthopedic surgeons on arthroscopic techniques to repair injuries on large joints on military service members.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · Q2
Heath care issues related to training military orthopedic surgeons on arthroscopic techniques to repair injuries on large joints on military service members.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · RR
Creation of program within DOD to help train military orthopedic surgeons to perform arthroscopic surgery to repair injuries to the major joints of military personnel injured performing various activities.
FORREST GENERAL HOSPITAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · fourth_quarter · Q4
Health Care Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLASMA PROTEIN THERAPEUTICS ASSOCIATION via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · fourth_quarter · Q4
Medicare reimbursement relating to plasma protein therapies; H.R. 2581, Preservation of Access for Seniors in Medicare Advantage Act of 2015, and H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015, provisions related to DME infused drugs; H.R. 6, 21st Century Cures Act, provisions related to DME infusion drugs. Medicare reimbursement methodology for DME infused drugs, generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED INFUSION SERVICES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · fourth_quarter · Q4
Medicare Billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARRIVA MEDICAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · fourth_quarter · Q4
Medicare DME Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIABETES MANAGEMENT & SUPPLIES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · fourth_quarter · Q4
Medicare DME Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES MEDICAL SUPPLY via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · fourth_quarter · Q4
Medicare DME reimbursement, Audit issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC WASHINGTON, DC, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · fourth_quarter · Q4
Legislative & regulatory issues related to biodefense countermeasure development, including the FY16 Labor HHS Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC WASHINGTON, DC, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · third_quarter · Q3
Legislative & regulatory issues related to biodefense countermeasure development, including the FY16 Labor HHS Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARECORE NATIONAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · fourth_quarter · Q4
Health care financing; implementation of "Protecting Access to Medicare Act of 2014".
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELEN KELLER NATIONAL CENTER via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · fourth_quarter · Q4
FY16 Labor-HHS-Education Appropriations Legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC WASHINGTON, DC, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · Q2
Legislative & regulatory issues related to biodefense countermeasure development, including the FY16 Labor HHS Appropriations Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC WASHINGTON, DC, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · RR
Project BioShield, biodefense; vaccine research; development, manufacturing and marketing infectious diseases; cancer.
Project BioShield, biodefense; vaccine research; development, manufacturing and marketing infectious diseases; cancer.
Project BioShield, biodefense; vaccine research; development, manufacturing and marketing infectious diseases; cancer.
ADVANCED INFUSION SERVICES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · third_quarter · Q3
Medicare Billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARRIVA MEDICAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · third_quarter · Q3
Medicare DME Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIABETES MANAGEMENT & SUPPLIES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · third_quarter · Q3
Medicare DME Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORREST GENERAL HOSPITAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · third_quarter · Q3
Health Care Reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES MEDICAL SUPPLY via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · third_quarter · Q3
Medicare DME reimbursement, Audit issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELEN KELLER NATIONAL CENTER via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · third_quarter · Q3
FY16 Labor-HHS-Education Appropriations Legislation.
FY16 Labor-HHS-Education Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARECORE NATIONAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · third_quarter · Q3
Health care financing; implementation of "Protecting Access to Medicare Act of 2014".
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions affecting community health centers; H.R. 2, Medicare Access & CHIP Reauthorization Act of 2015, provisions affecting community health centers; funding for community health centers, generally.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
HELEN KELLER NATIONAL CENTER via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · Q2
FY16 Labor-HHS-Education Appropriations Legislation.
FY16 Labor-HHS-Education Appropriations Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARECORE NATIONAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · Q2
Health care financing; implementation of "Protecting Access to Medicare Act of 2014".
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES MEDICAL SUPPLY via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · Q2
Medicare DME reimbursement, Audit issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORREST GENERAL HOSPITAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · Q2
Health Care Reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
DIABETES MANAGEMENT & SUPPLIES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · Q2
Medicare DME Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARRIVA MEDICAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · Q2
Medicare DME Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED INFUSION SERVICES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · second_quarter · Q2
Medicare Billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · first_quarter · Q1
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
GENERIC PHARMACEUTICAL ASSOCIATION via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · first_quarter · 1T
Issues relating to biosimilar regulation.
Issues relating to FDA REMS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORREST GENERAL HOSPITAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · first_quarter · Q1
Health Care Reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
DIABETES MANAGEMENT & SUPPLIES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · first_quarter · Q1
Medicare DME Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARRIVA MEDICAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · first_quarter · Q1
Medicare DME Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED INFUSION SERVICES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · first_quarter · Q1
Medicare Billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES MEDICAL SUPPLY via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · first_quarter · Q1
Medicare DME reimbursement, Audit issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRIENDS OF THE GLOBAL FIGHT via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · first_quarter · Q1
Legislative proposals and regulatory policies affecting programs and funding to combat AIDS, tuberculosis and malaria. State/Foreign Operations Appropriations for FY2016, provisions on global health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARECORE NATIONAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · first_quarter · Q1
Health care financing; implementation of Sustainable Growth Rate Formula legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2015 · first_quarter · RR
Implementation of Public Law No. 111-148, provisions affecting community health centers.
GENERIC PHARMACEUTICAL ASSOCIATION via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · fourth_quarter · 4T
Issues relating to biosimilar regulation.
Issues relating to FDA REMS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL GROUND WATER ASSOCIATION via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · fourth_quarter · Q4
National Ground water monitoring network funding. Monitor Geothermal Heat pump legislation. Monitor Tax Reform Discussion
Filing targets: Agriculture, Dept of (USDA), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
FORREST GENERAL HOSPITAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · fourth_quarter · Q4
Health Care Reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS)
UNITED STATES MEDICAL SUPPLY via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · fourth_quarter · Q4
Medicare DME reimbursement, Audit issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERIC PHARMACEUTICAL ASSOCIATION via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · fourth_quarter · Q4
Issues relating to FDA REMS
Issues relating to biosimilar regulation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIABETES MANAGEMENT & SUPPLIES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · fourth_quarter · Q4
Medicare DME Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARRIVA MEDICAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · fourth_quarter · Q4
Medicare DME Reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALL AMERICAN MEDICAL SUPPLIES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · fourth_quarter · Q4
Medicare DME reimbursement, Audit issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED INFUSION SERVICES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · fourth_quarter · Q4
Medicare Billing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRIENDS OF THE GLOBAL FIGHT via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · fourth_quarter · Q4
Legislative proposals and regulatory policies affecting programs and funding to combat AIDS, tuberculosis and malaria. State/ Foreign Operations Appropriations for FY2015, provisions on global health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARECORE NATIONAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · fourth_quarter · Q4
Health care financing; implementation of sustainable Growth Rate Formula legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES MEDICAL SUPPLY via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · third_quarter · Q3
Medicare DME reimbursement, Audit issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SINGING RIVER HOSPITAL SYSTEM via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · third_quarter · Q3
Health Care Reimbursement
PATHGROUP, INC. via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · third_quarter · Q3
Medicare Reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OCHSNER HOSPITAL SYSTEM via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · third_quarter · Q3
Medicare Reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEMORIAL HOSPITAL AT GULFPORT via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · third_quarter · Q3
Health Care Reimbursement, DSH payments
HATTIESBURG CLINIC via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · third_quarter · Q3
Medicare Reimbursement
Medicare Reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERIC PHARMACEUTICAL ASSOCIATION via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · third_quarter · Q3
Issues relating to biosimilar regulation
Issues relating to FDA REMS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FORREST GENERAL HOSPITAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · third_quarter · Q3
Health Care Reimbursement, DHS payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIABETES MANAGEMENT & SUPPLIES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · third_quarter · Q3
Medicare DME Reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARRIVA MEDICAL via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · third_quarter · Q3
Medicare DME Reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALL AMERICAN MEDICAL SUPPLIES via BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ
2014 · third_quarter · Q3
Medicare DME reimbursement, Audit issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Project BioShield, biodefense; vaccine research; development, manufacturing and marketing infectious diseases; cancer.
Project BioShield, biodefense; vaccine research; development, manufacturing and marketing infectious diseases; cancer.